CFI-400945 - Moligand™, ≥97% , Inhibitor of polo like kinase 4, CAS No.1338806-73-7, Inhibitor of polo like kinase 4

CAS: 1338806-73-7 Cat. No.: C413779 분자식: C33H34N4O3 분자량: 534.65 PubChem CID: 58486178
주문 가능
등급 & 순도 Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥97%
Synonyms
CFI-400945 (free base)|(1R,2S)-2-(3-((E)-4-(((2R,6S)-2,6-dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one|(1r,2s)-2-(3-((e)-4-(((2r,6s)-2,6-dimethyl morpholino)methyl)styryl)-1h-indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one|Spiro[cyclopropane-1,3'-[3H]indol]-2'(1'H)-one, 2-[3-[(1E)-2-[4-[[(2R,6S)-2,6-dimethyl-4-morpholinyl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5'-methoxy-, (1R,2S)-|ocifisertib [INN]|(2'S,3R)-2'-[3-[(E)-2-[4-[[(2S,6R)-2,6-dimethylmorpholin-4-yl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5-methoxyspiro[1H-indole-3,1'-cyclopropane]-2-one|CFI-400945 free base|(1R,2S)-2-{3-[(E)-2-(4-{[(2R,6S)-2,6-dimethylmorpholin-4-yl]methyl}phenyl)ethen-1-yl]-1Hindazol-6-yl}-5'-methoxyspiro[cyclopropane-1,3'-indol]-2'(1'H)-one|(2'S,3R)-2'-[3-[(E)-2-[4-[[(2R,6S)-2,6-dimethylmorpholin-4-yl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5-methoxyspiro[1H-indole-3,1'-cyclopropane]-2-one|ocifisertib|Spiro(cyclopropane-1,3'-(3H)indol)-2'(1'H)-one, 2-(3-((1E)-2-(4-(((2R,6S)-2,6-dimethyl-4-morpholinyl)methyl)phenyl)ethenyl)-1H-indazol-6-yl)-5'-methoxy-, (1R,2S)-|CFI-400945,|CFI-400945|(1R,2S)-2-[3-[(1E)-2-[4-[[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5'-methoxyspiro[cyclopropane-1,3'-[3H]indol]-2'(1'H)-one
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
크기
USA
독일 (EU)*
가격
수량
1mg
C413779-1mg
2 재고 있음
—

US$76.90

US$89.90
저장 US$13.00 (14.46%)
5mg
C413779-5mg
2 재고 있음
—

US$228.90

US$312.90
저장 US$84.00 (26.85%)
10mg
C413779-10mg
2 재고 있음
—

US$370.90

US$480.90
저장 US$110.00 (22.87%)
25mg
C413779-25mg
2 재고 있음
—

US$741.90

US$1,167.90
저장 US$426.00 (36.48%)
50mg
C413779-50mg
2 재고 있음
—

US$1,185.90

US$1,974.90
저장 US$789.00 (39.95%)
100mg
C413779-100mg
2 재고 있음
—

US$2,285.90

US$2,963.90
저장 US$678.00 (22.88%)
Enter a quantity for the sizes you want to add.

개요

Information

CFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.


Targets

PLK4 (Cell-free assay); TrkA (Cell-free assay); TrkB (Cell-free assay); Tie-2 (Cell-free assay); Aurora B (Cell-free assay) 16539,2.8 nM; 6 n


In vitro

CFI-400945 is a potent, orally active antitumor agent with the IC50 and Ki values of 2.8 and 0.26 nM, respectively. No significant inhibition against PLKs 1-3 is observed for CFI-400945 at a concentration of 50 μM. CFI-400945 can attenuate the growth of breast cell line, as well as other tumor cell lines significantly. CFI-400945 selectively inhibits PLK4 in cells, but also has certain activity against AURKB, TRKA, TRKB and Tie2/TEK (only 10 kinases showed more than 50% inhibition among 290 kinases). The cytokinesis failure and subsequent polyploidization by CFI-400945 treatment indicate that the cell death in cancer cell lines is at least partly achieved through inhibition of AURKB. No significant inhibition is observed for PLKs 1-3 (IC50s > 50 μM) probably due to the most divergent structure of PLK4 compared to other polo-like kinases 1-3. Cancer cells treated with CFI-400945 exhibit effects consistent with PLK4 kinase inhibition, including dysregulated centriole duplication, mitotic defects, and cell death.


In vivo

CFI-400945 is well tolerated in breast cancer xenograft models, in particular those deficient in the tumor suppressor PTEN. Upon intermittent oral dosing, in a mouse model of colon cancer, CFI-400945 is an effective inhibitor of HCT116 tumor growth and was well tolerated. CFI-400945 is absorbed rapidly after oral administration, reaching maximum plasma concentrations (Cmax) of 0.25-11.68 μg/mL for the doses tested (3.75-104 mg/kg). CFI-400945 can inhibit the growth of a range of tumor types and may be effective in a clinical setting even in advanced tumors. Following oral administration of efficacious doses of CFI-400945 in mice, plasma levels of CFI-400945 are sustained and remained above both the EC50 value for half-maximal inhibition of cellular PLK4 autophosphorylation and growth inhibition GI50 values for 24 hr. Moreover, CFI-400945 demonstrates dose-dependent antitumor activity. Analysis of xenograft tumors from mice treated with an efficacious dose of CFI-400945 shows a pharmacodynamic effect that is suggestive of complete rather than partial inhibition of PLK4 kinase activity.


Cell Research(from reference)

Cell lines:MDA-MB-468, MCF-7, HCC1954, MDA-MB-231, SKBr-3, Cal-51, and BT-20 breast cancer cells 

Concentrations:10 nM to 50 μM 

Incubation Time:5 d 

사양

동의어
CFI-400945 (free base) | (1R,2S)-2-(3-((E)-4-(((2R,6S)-2,6-dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one | (1r,2s)-2-(3-((e)-4-(((2r,6s)-2,6-dimethyl morpholino)methyl)styryl)-1h-indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one | Spiro[cyclopropane-1,3'-[3H]indol]-2'(1' Show more
사양 및 순도
Moligand™, ≥97%
생화학 및 생리적 메커니즘
CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.
보관 조건
Store at -20°C
배송
Ice chest + Ice pads
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
등급
Moligand™
작업 유형
INHIBITOR
작동 메커니즘
Inhibitor of polo like kinase 4
순수함
≥97%
이름과 식별자
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504771684
SMILES
CC1CN(CC(O1)C)CC2=CC=C(C=C2)C=CC3=NNC4=C3C=CC(=C4)C5CC56C7=C(C=CC(=C7)OC)NC6=O
IUPAC Name
(2'S,3R)-2'-[3-[(E)-2-[4-[[(2R,6S)-2,6-dimethylmorpholin-4-yl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5-methoxyspiro[1H-indole-3,1'-cyclopropane]-2-one
InChIKey
DADASRPKWOGKCU-FVTQAUBDSA-N
InChI
1S/C33H34N4O3/c1-20-17-37(18-21(2)40-20)19-23-6-4-22(5-7-23)8-12-29-26-11-9-24(14-31(26)36-35-29)28-16-33(28)27-15-25(39-3)10-13-30(27)34-32(33)38/h4-15,20-21,28H,16-19H2,1-3H3,(H,34,38)(H,35,36)/b12-8+/t20-,21+,28-,33-/m0/s1
이성체 SMILES
C[C@@H]1CN(C[C@@H](O1)C)CC2=CC=C(C=C2)/C=C/C3=NNC4=C3C=CC(=C4)[C@@H]5C[C@]56C7=C(C=CC(=C7)OC)NC6=O
PubChem CID
58486178
분자량
534.65

고급 데이터

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
분류Benzopyrazoles
SubclassIndazoles
Intermediate Tree Nodes Not available
Direct ParentIndazoles
Alternative Parents Indolines  Anisoles  Benzylamines  Phenylmethylamines  Styrenes  Alkyl aryl ethers  Aralkylamines  Morpholines  Heteroaromatic compounds  Pyrazoles  Lactams  Trialkylamines  Amino acids and derivatives  Secondary carboxylic acid amides  Oxacyclic compounds  Dialkyl ethers  Azacyclic compounds  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Indazole - Indole or derivatives - Dihydroindole - Benzopyrazole - Benzylamine - Anisole - Phenol ether - Phenylmethylamine - Styrene - Aralkylamine - Alkyl aryl ether - Benzenoid - Morpholine - Monocyclic benzene moiety - Oxazinane - Heteroaromatic compound - Azole - Pyrazole - Secondary carboxylic acid amide - Lactam - Carboxamide group - Amino acid or derivatives - Tertiary amine - Tertiary aliphatic amine - Oxacycle - Ether - Azacycle - Dialkyl ether - Carboxylic acid derivative - Organic nitrogen compound - Carbonyl group - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organic oxide - Organic oxygen compound - Amine - Aromatic heteropolycyclic compound
설명This compound belongs to the class of organic compounds known as indazoles. These are compounds containing an indazole, which is structurally characterized by a pyrazole fused to a benzene.
External Descriptors Not available
3D 구조
상호 작용 화학 구조 모델





관련 대상(인간)
CYP2C9 Tchem Cytochrome P450 2C9 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TEK Tclin Angiopoietin-1 receptor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLK4 Tchem Serine/threonine-protein kinase PLK4 (6 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NTRK2 Tclin BDNF/NT-3 growth factors receptor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NTRK1 Tclin High affinity nerve growth factor receptor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

7 results found

Lot NumberCertificate Type날짜항목
C2624008C2624008Certificate of AnalysisApr 07, 2026 C413779
K2212319K2212319Certificate of AnalysisAug 12, 2025 C413779
K2212324K2212324Certificate of AnalysisAug 12, 2025 C413779
K2212329K2212329Certificate of AnalysisAug 12, 2025 C413779
K2212331K2212331Certificate of AnalysisAug 12, 2025 C413779
K2212336K2212336Certificate of AnalysisAug 12, 2025 C413779
K2212358K2212358Certificate of AnalysisAug 12, 2025 C413779
화학 및 물리적 특성
용해성Solubility (25°C) In vitro DMSO: 100 mg/mL warmed with 50ºC Water: bath (187.03 mM); Ethanol: 100 mg/mL (187.03 mM); Water: Insoluble;
분자량534.6
XLogP34.700
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count6
Exact Mass534.263 Da
Monoisotopic Mass534.263 Da
Topological Polar Surface Area79.500 Ų
Heavy Atom Count40
Formal Charge0
Complexity942.000
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds1
Covalently-Bonded Unit Count1
솔루션 계산기
리뷰

고객 리뷰

등급 선택에 도움이 필요하신가요?

당사의 등급 선택 가이드는 카탈로그의 모든 변형 제품에 대해 순도, 안정제 상태 및 용도 적합성을 다룹니다.

Moligand™ 등급 가이드 보기 →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.